SynBioVen

SynBioVen is a London-based venture capital firm established in early 2022, dedicated to supporting the next generation of synthetic biology scientists, founders, and startups. The firm focuses on early-stage investments, providing proof-of-concept, pre-seed, and seed funding to innovative teams aiming to revolutionize industries through synthetic biology. SynBioVen believes that synthetic biology will drive the next industrial revolution and the transition to a net-zero economy, with UK companies playing a leading role.

The firm's investment strategy emphasizes early-stage support, offering access to a team with expertise in synthetic biology research, business development, and financing. SynBioVen also provides portfolio companies with access to dedicated technical teams at SynbiCITE and facilities like the London Biofoundry, aiding in de-risking and scaling their innovations. The firm has invested in companies such as Colorifix, which has developed a revolutionary dyeing process to help the textile industry reduce its environmental impact, and Scindo, which develops a novel biological platform to turn low-value plastic landfill waste into high-value molecules.

SynBioVen's mission is to empower synthetic biology ventures by providing critical funding, strategic mentorship, and access to cutting-edge facilities, ensuring that the next generation of engineering biology companies can thrive. The firm's team comprises industry leaders with extensive experience in biotech commercialization, venture building, and global industry networks, committed to fostering innovation and driving advancements in the synthetic biology sector.